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Abstract

Schlachter, Kelly Wilton. MSME. The University of Memphis. December 2011.
Design of a Metatarsophalangeal Joint Implant Wear Tester. Major Professor: Dr.
Gladius Lewis.

The purpose of the present study was to design a wear tester for implants of the first
metatarsophalangeal joint (FMTPJ), otherwise known as the first joint of the big toe.
Many different designs of this type of implant from many manufacturers are currently in
clinical use, but there is no information in the open literature as to how these implants are
tested for in vivo durability. There are several case studies, however, in which premature
implant fractures were reported. It is possible that the incidence of such fractures might
have been lower if standardized wear testing of FMTPJ implants existed. We studied the
development history of FMTPJ implants, the designs of implants currently in clinical use;
current wear test methods used on hip and knee implants, the biomechanics of the
FMTPJ, and designed a wear tester that could be used to test current and future implant
designs in vitro. A stress analysis of the tester indicated that any failure would occur at
the implant/fixture interface and that the machine can test at forces beyond what has been
observed in the normal gait.
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Introduction
Background and Motivation
There is no doubt that the great toe is the most important digit in the foot. When it
comes to balance and propulsion, the great toe shoulders the majority of the loads placed
on the digits, with the lesser toes balancing out the rest (1). The first joint of the big toe,
called the first metatarsophalangeal joint (FMTPJ), is affected by many degenerative
diseases. At the later stages of these diseases, a treatment that is widely used to alleviate
pain and to restore joint function is a FMTPJ implant.
Total joint replacements have been around since the late 1800s (2). The earliest
recorded total hip joint replacements (THJRs) and total knee joint replacements (TKJRs)
were performed around 1891 (2). Today, there are approximately 200,000 THJRs and
500,000 TKJRs implanted in the United States every year (jisrf.com). These
arthroplasties are well established surgical procedures and the implants associated with
these procedures have been extensively tested using international standards; namely,
ISO14242 (3) and ISO14243 (4). These standards contain, among other things, details of
protocols for wear testing of an implant as well as of the method for determining the
amount of wear.
In contrast to THJRs and TKJRs, there are currently no industry standards for the
wear performance of FMTPJ implants. This is a consequence of the fact that, while there
are many types and designs of FMTPJ implants and a large collection of manufacturers
that design and/or fabricate/produce them, there is nothing in the open literature on wear
testing of these implants. Just as a hip or knee implant, a FMTPJ implant articulates with
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the contiguous bones or secondary components throughout its life and, thus, has potential
for generating wear debris or for fracturing.
Hinged FMTPJ implants fabricated from a polysiloxane (Silastic®) have been
around since the 1970s and are still popular in clinical use today (5). Failures of these
implants have included deformation, fracture, and abrading (6,7). There are no long-term
follow-up clinical data on metal hemi-implants and multi-component totals implants.
There are, however, several case studies involving examination of explanted implants, in
which excessive surface wear, debris in the surrounding tissue, and fracture, have been
observed (8,9,10). Although the results of in vitro wear testing do not necessarily predict
the life expectancy or the in vivo wear performance of an implant, they provide valuable
insight into the wear resilience of the implant and may be used to screen sets of implant
designs.
Study Purposes
The purposes of the present work were two-fold. The first was to design a FMTPJ
implant wear tester whose motion cycles replicate those that occur at the joint during
activities of daily living, especially walking, and is not only capable to use to evaluate
implant designs that are in current clinical use but is also adaptable to test future implant
designs. The second was to present the essential features of a protocol to be used with the
designed tester.
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Background
Anatomy of the FMTPJ
The foot is divided up into three sections; namely, the hind-foot, the mid-foot, and
the fore-foot. There are 28 bones, 19 intrinsic muscles, 38 tendons, and over 100
ligaments in the foot and ankle (11). The hind-foot includes the heal, the mid-foot
includes the arch of the foot, and the fore-foot includes the metatarsals and phalanges of
the toes (Figure 1). The FMTPJ comprises the metatarsal and proximal phalanx bones
and, to a lesser degree, the sesamoids (Figure 2). Several ligaments surround the joint for
stabilization, including the medial collateral, lateral collateral, and plantar ligaments (6).
The extensor hallucis longus and brevis are the tendons responsible for dorsiflexion, the
flexor hallucis longus and brevis are responsible for plantarflexion, the abductor hallucis
are responsible for abduction, and the adductor hallucis are responsible for adduction
(11,12). The FMTPJ is composed of a cartilage-lined metatarsal head and phalanx base to
allow “frictionless motion” and is also surrounded by a capsule for static stability (13).

Figure 1. Medial View of the Right Foot (14).
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Figure 2. Schematic Diagram Showing Key Features of the FMTP joint (6).

Physiology of the FMTPJ
Feet are the structural supports of the body that allow upright locomotion and are
designed to handle repetitive loads of multiples of bodyweight (11). The network of
bones, ligaments, tendons, and muscles are able to adjust to different ground contours and
provide acceleration. The fore-foot can experience loads up to 1.2 x bodyweight during
toe push off in normal walking, with the FMTPJ taking up to bodyweight at its peak (15).
The FMTPJ is capable of handling these loads while maintaining its normal functions of
plantarflexion (lowering), dorsiflexion (raising), adduction (bringing toes together) and
abduction (spreading toes apart) (16) as shown in Figure 3. The FMTPJ is also capable of
being very flexible to allow bending and crouching, but can become rigid to transfer
weight-bearing forces during propulsion (11). Motion includes the base of the phalanx
gliding over the head of the metatarsal with the sesamoid bones, embedded in the flexor
tendons, sliding over the joint and keeping the tendons from flattening out (11).

4

Figure 3. Motions of the Foot (11).

Kinematics and Kinetics
FMTPJ motion includes flexion, extension, adduction, and abduction (Figure 3)
(11,17). Range of motion is discussed frequently in the literature as it is one of the
primary parameters used to determine the stage of joint deterioration, which treatment
option to use, and the success or otherwise of the treatment outcome (18-20). Normal
passive range of motion for a FMTPJ ranges from 90o dorsiflexion to 30o planterflexion
with respect to the metatarsal axis, which is already at about a 25o angle with respect to
the floor (11). The range of motion measured during walking is much less, but there are
differences in opinion about the magnitude of the range. This is a consequence of the
many different measurement/determination methods used (18,21,22).
5

Most of the literature reports on the determination of forces experienced by the
feet during various activities of daily living have focused on the normal gait cycle
(Figure 4). This cycle can be broken up into two phases, the stance phase and the swing
phase (11). The stance phase is 62% of the cycle and starts with the heel striking the
ground, then moves on to the foot going flat, heel rise and finally push off, or toe off (11).
The swing phase is 38% of the cycle and includes acceleration, toe clearance, and
deceleration (11). It is to be noted that the FMTPJ was the subject in only a few of the
aforementioned studies.

Figure 4. The Normal Gait Cycle (38).

Using radiographs of healthy feet to determine the geometries of the fore-foot and
the angles it made with the ground, during the gait cycle, Stokes et al (15), using vertical
ground reaction forces, calculated the force across the FMTPJ to be comparable to body
weight. Jacob (1) also calculated the force placed on the FMTPJ by measuring the
vertical ground reactions during normal gait cycle, but refined the analysis by creating
6

free body diagrams of the known geometries of the bones and the tendons, and calculated
the resultant force that acted on the first metatarsal head based on the reaction forces of
these tendons. Jacob calculated the force to be around 86% of body weight (1).
Pathophysiology of the FMTPJ and Treatment Options
There are many ailments that affect the FMTPJ, examples being osteoarthritis,
rheumatoid arthritis, trauma/fracture, gout, bone/tissue deformities, bone spurs, and failed
previous joint operations (23-25). These ailments can lead to many disorders, such as
hallux valgus (bunion), hallux rigidus/limitus (diminished range of motion), hallux varus
(typically, a postoperative deformity), sesamoid disorders, pain, and cosmetic disorders
(26). If left untreated, these problems may lead to physiologic compromises, such as
severe pain, difficulty in walking and a limited choice when it comes to footwear.
The many treatment options that are available may be grouped into two
categories; one involving joint preservation and the other joint destruction. Joint
preservation procedures can further be classified as surgical and nonsurgical. The first
options for patients with early symptoms usually involve a conservative approach, such
as use of anti-inflammatory drugs, orthotics, splinting, and casting (27). The goals of
these options are to provide pain relief and, possibly, to delay the need for surgery. When
a disorder progresses beyond what can be treated non-surgically, joint preservation
surgical procedures are recommended. These surgical procedures involve cheilectomy, or
the removal of bone spurs; soft tissue correction to force the toe back into alignment; and
osteotomy, which is the removal a section or wedge of bone to realign the FMPTJ joint
(20,24,26,27). For late stages of degenerative diseases of the FMTPJ, the only options
are, usually, joint destructive ones (19). Three of the most widely used of these options
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are arthrodesis, which is the fusion of the FMTP; implant arthroplasty, the partial or full
replacement of the FMTPJ with an implant; and joint resection arthroplasty (Keller
procedure) (19,23).
The first reported arthrodesis was performed in 1852 (19,23). Since then,
arthrodesis has become the preferred treatment for patients in the advanced stages of
degenerative joint disease (28). The primary goal of this procedure is pain relief and to
restore some function of the toe. With a successful arthrodesis, the patient is again able to
place his/her full body weight on the foot because the fused joint is able to distribute the
loads across both the metatarsal and the first phalanx (26). Although, as a result of the
fusion, all joint motion is lost, the success rate of arthrodesis, as measured by, for
example, long-term pain relief, is very high (19,23).
The goals of a FMTPJ implant is to relieve pain and to restore function at the joint
(37). Because it preserves some range of motion, implant arthroplasty is considered a
viable option for treating late- or end-stage degenerative diseases, especially in more
active patients (16,29). Insurance companies are also starting to recognize that a FMTPJ
implant is a viable alternative to arthrodesis and are beginning to cover the cost of the
procedure (30,31). As improvements in designs are introduced and more favorable results
are reported, more surgeons will consider implant arthroplasty for late stage joint
degenerative disease in the FMTPJ (29).
Joint resection arthroplasty was introduced in the early 1900s and involves only
removing the damaged part of the metatarsal head or phalanx base (19). This procedure
alleviates pain and still allows for a range of motion; however, the amount of articulating
surface remaining on the operated bony surface is reduced. Complications include
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“floating hallux” and transfer metatarsalgia, or increased pressure/pain on the ball of the
foot (19,32). Although this is a joint destructive procedure, enough of the bone remains to
do a follow-up arthrodesis or implant arthroplasty at a later date, if needed (32).
FMTPJ Implant Designs
One of the first recorded attempts at FMTPJ implant arthroplasty was performed
by Ender, who, in 1951, used an acrylic bone cement to re-create the base of a proximal
phalanx (5). In 1952, Swanson fabricated a hemi-implant from metal to replace the head
of the first metatarsal (5). In 1964, Seeburger introduced another hemi-implant, using
Durallium® (a Ni-Co-Cr-Cu-Mg-Mn-Mo-Si alloy; www.lookchem.com) to create three
different versions of the metatarsal head (5). Also, in 1964, Joplin used Vitallium (a CoCr-Mo alloy; www.lookchem.com) to create two different hemi-implant designs, one for
the head of the metatarsal and the other for the base of the phalanx (5). In 1965, Swanson
revised his original hemi-implant design by changing the material to silicone and, in
1967; he introduced a stemmed implant for the base of the phalanx, fabricating it from
Silastic (5). A double-stemmed hinged implant, designed by Kampner, was introduced by
a manufacturer, Cutter, in 1971 and, in 1974, another company, Dow Corning, introduced
another of this type of implant; namely, the Swanson Flexible Hinge (5). The first multicomponent implant, designed by Weil and Smith, was introduced in 1975 by Richards
Manufacturing and comprised a stainless steel metatarsal component and an ultra-high
molecular weight polyethylene (UHMWPE) phalanx component (5). The current
generation of FMTPJ implants are, essentially, variants of these three types of designs;
namely, hemi-, double-stemmed, and multi-component (Table 1).
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Table 1. Some Features of a Sample of Current Generation FMTP Joint Implants
Manufacturer
Implant Name
Materials
Implant Type
Arthrosurface
(Franklin, MA)

Hemi Cap

CoCr/Ti

Hemi-Phalanx

Ascension Ortho
(Austin, TX)

Movement™ Great Toe
System

CoCr/UHMWPE

Total

BioPro
(Port Huron, MI)

Great Toe Hemi

CoCr

Hemi-Phalanx

Integra Life Sciences
(Plainsboro, NJ)

K2 Hemi Toe Implant
System
KGTI Kinetic Great Toe
Implant

CoCr

Hemi-Phalanx

CoCr/Ti/UHMWPE

Total

MetaSurge
(Houston, TX)

Biomotion

Ti

Hemi-Phalanx

Moje Ceramic Implants
(Petersberg, Germany)

Moje

Zirconium dioxide
Zirconium dioxide

Hemi-Metatarsal and
Hemi-Phalanx
Total

OrthoPro
(Salt Lake City, UT)

Metal Hemi

CoCr/Ti Plasma

Hemi-Phalanx

Osteomed
(Addison, TX)

Bioaction™ Great Toe
Implant
Encompass™ Metatarsal
Resurfacing Implant
Hemi™ Great Toe Implant
ReFlexion 1st MPJ Implant
System

CoCr/UHMWPE

Total

CoCr/Ti Plasma/HA

Hemi-Metatarsal

CoCr
Ti/UHMWPE

Hemi-Phalanx
Total

Sgarlato Medical
(San Jose, CA)

GAIT GTI

Silicone

Hinged

Smith & Nephew
(Baar, Switzerland)

Toefit Plus™

Ti/UHMWPE

Total

Tornier
(Edina, MN)

Futura™ Primus
Futura™ Classic
Futura™ Metal Hemi

Silicone/Ti Grommets
Silicone
CoCr

Hinged
Hinged
Hemi-Phalanx

Trilliant
(Houston TX)

3S Hemi Implant

CoCr

Hemi-Phalanx

Wright Medical
(Arlington, TN)

LPT Great Toe Implant
Swanson Flexible Hinge
Toe

Ti
Silicone/Ti Grommets

Hemi-Phalanx
Hinged

Vilex
(McMinnville, TN)

CHI™

CoCr or Ti

Hemi-Metatarsal and
Hemi-Phalanx
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Design, Operation, and Stress Analysis
Design Requirements for the Wear Tester
ISO 14242 (3) and ISO 14243 (4) are international standards for wear testing hip and
knee implants. Using these standards as guides and results given in literature reports
regarding the range of motion and forces experienced by the FMTPJ during the normal
gait cycle, the following were identified as the design requirements for the wear tester:
1. Implant to be immersed in bovine solution, at 37 oC.(3,4)
2. Implant to be subjected to a loading cycle at a frequency of 1 Hz.(3,4)
3. Range of motion to be no less than 40o.(18,21,22)
4. Capable of applying force of at least 600 N during articulation.(1,15)
5. Mounting for implant must be adaptable to accommodate any type of implant
(Table 1)
Details of the Designed Wear Tester
Solid models of the various components of the wear tester were created using a
commercially-available software package (Pro-E Wildfire 3.0; PTC, Needham, MA) and
are presented in Figures 6-9. The list of materials for the machine components is given in
Table 2 and a 2D schematic drawing is shown in figure 5. Minus any engineering and
programming fees, the tester should cost around $15,000 to build.
The wear tester will contain four stations; one station provides the static load for
the control implant while the other three provide load plus articulation for the implant
under test. By placing the articulating arms overhead and mounting the specimen on a
dropped mount, 40o of articulation will be possible. A motor attached to a 90o gear box
and mounted to one of the articulating stations will provide the motion. The hydraulic
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piston, located at the base of each station, will be attached to a load cell that will provide
feedback to the pump. This will provide the requisite load of 600 N.

Table 2. List of basic components of the wear tester.
Component
Material
Machine Base
6061-T6 Al alloy

Qty
1

Machine Side

6061-T6 Al alloy

2

Articulating Arm

6061-T6 Al alloy

8

Articulating Cross-member

6061-T6 Al alloy

4

Drop Mount

6061-T6 Al alloy

4

Mounting Base

6061-T6 Al alloy

4

Metatarsal Implant Mount

ABS-Like SLA

4

Phalangeal Implant Mount

ABS-Like SLA

4

Serum Cup

UHMWPE/Polycarbonate

4

Load Cell

Various

4

Load Cell Mount

6061-T6 Al alloy

4

Hydraulic/pneumatic Piston

Various

4

Articulating Lever

6061-T6 Al alloy

3

Lever Actuator

6061-T6 Al alloy

1

1kw Motor

Various

1

90o Gearbox

Various

1

Controller

2

Software
Pump w/heated bath

1

ABS: acryl obutyl styrene; SLA: stereolithography
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Figure 5. 2D Schematic Drawing of Wear Tester
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A solid model of the assembled designed wear tester is presented in Figure 6.
Outside overall dimensions are approximately 24” wide, 9” deep and 17 ¼” tall, not
including the motor/gearbox or cabinet. Articulation occurs in the dorsiflexion range to
40o, away from the static load station to allow for clearance. The motor/gear box
assembly will mount to the rotational axis of the center articulating station, which will
then drive the remaining articulating stations.

Figure 6. Solid Model of the Assembled Wear Tester
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A cut-away model showing the implant, located in the first of the articulating
stations, is presented in Figure 7. The overhead mount allows for complete immersion of
the implant in the bovine serum, which can be pumped in from the open top to maintain
the required 37o C. The center of rotation of the metatarsal component is lined up with
the center of rotation of the articulating arm.

Figure 7. Solid Model of Cut-Away View of One of the Articulating Stations
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A close-up of the metatarsal component resting on the surface of the UHMWPE
insert to the phalanx component is given in Figure 8. The metatarsal component mount
can be shimmed or shaved to insure proper alignment to the center of rotation. The
hydraulic piston provides the lift to bring the phalanx component into contact with the
metatarsal component.

Figure 8. Solid Model: Close-Up View of Implant Mounted in the Wear Tester

Solid models of the key components that allow the wear tester to be adaptable to
different types of implants (Table 1) are given in Figure 9. The dynamic components of
the machine were designed to mimic the biomechanics of the FMTPJ. The component
mounts are disposable pieces created using a rapid prototyping method, such as
stereolithography. For each implant to be tested, a solid model will be created using a
commercially-available software package or acquired from the manufacturer. The model
will then be used to create the cavity in the mount and then the length of the mount will
16

be adjusted to line up the center of rotation of the implant to that of the tester. The
implant will be mounted in the wear tester fixtures in the same way as is done during an
implantation procedure; that is, cemented in a bed of acrylic bone cement or press fitted.

Figure 9. Solid Models of the Component Mounts

Operation of the Designed Wear Tester
The dynamic components of the wear tester will be controlled with motors,
encoders, controllers, and software. An electric motor rating: 1kW, mounted to a 90o
speed reduction gearbox, will provide enough torque to articulate the overhead arms. This
assembly will attach to one of the articulating stations, which will then drive a lever to
articulate the other two articulating stations. Commercially-available software package
such as FlexTest® (MTS; Eden Prairie, MN), Pro-Motion® (PMD; Boxborough, MA), or
Visual Basic® (Microsoft; Redmond WA), will be used to program the controllers. This
software will read the information from the encoder to set amount of desired articulation,
the frequency of that articulation, as well as keeping up with the cycle count. At the same
time, the software will be tasked to control the pressure on the hydraulic pistons during
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key angles of articulation, by reading the feedback from the load cells and controlling the
pressure created by the hydraulic pump. This will cycle from almost no pressure at 0o
articulation and increase to the desired load as peak articulation is reached.
Stress Analysis of an Articulating Test Station
A commercially-available finite element analysis (FEA) package (ANSYS 11.0;
ANSYS Inc., Canonsburg, PA) was used to perform the stress analysis of an articulating
test station, at 0o articulation as well as at 40o articulation, to represent the full range of
motion that would be experienced by an implant during a wear test. The finite element
meshes of the station, at each of these articulations, obtained using tetrahedral elements
(17,711 Elements, 35,891 Nodes), are shown in Figures 10 and 11, respectively. Note the
high mesh density of the ABS-Like SLA fixture in recognition of the fact that the fixture
is expected to be the weakest component in the tester. Subsequent analyses were run
using more refined mesh sizes and a higher stressed element, located in the transition
between the shaft and taper on the drop leg, was followed to test for convergence. Table 3
lists the mesh details and the equivalent stress at the observed element. Little difference
was seen in the results so the original mesh was sufficient to produce accurate results.

Table 3. Results from Convergence Test
Mesh Details
# of Elements
von-Mises stress at transition
# of Nodes
point of drop leg [MPa]
Course
17,711
42.855
35,891
Medium

24,743
59,262

48.373

Fine

32,727
93,451

46.909
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Figure 10. 0o Meshed Structure

Figure 11. 40o Meshed Structure

For the analysis, a force of 1200 N was applied to the surface of the implant
(Figures 12 and 13). This force magnitude is twice what would be used during a test.
There are two reasons for this approach. First, it would allow investigation of the load
capacity of the wear tester. Second, it will allow evaluation of FMTPJ implants under
load conditions the joint experiences in activities other than normal gait. Note the mesh
display was turned off to highlight the direction of the applied load.
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Figure 12. 0o 1200 N Load

Figure 13. 40o 1200 N Load

Two key features of the von Mises stress contours for all the components in the
articulating test station, at 0o and 40o articulations (Figures 14 and 15) are noted. First,
the highest stress is at the implant-fixture interface, a finding that might help explain why
implant loosening is such a prevalent failure mode for the FMTPJ implants (10,28).
Second, the highest stress experienced in each of the other parts of the station is much
lower than the yield strength of 6061-T6 Al alloy (276 MPa; E=69GPa; ʋ=0.3) (39),
which indicates the high factor of safety of the station against elastic failure, when
subjected to a quasi-static load.
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Figure 14.

von Mises Stress Contour for a Test Station, at 0o Articulation.
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Figure 15. von Mises Stress Contour for a Test Station at 40o Articulation.

Proposed Wear Test Protocol
For a given implant, one control specimen and three test specimens should be
used. All specimens should be cleaned and weighed in a way that is similar to what is
specified in ISO 14243-2 (4). The control specimen will be placed under the same load
and in the same environment as the test specimens but not articulated during the test.
Thus, the control specimen will be used as a reference to determine weight gained while
being immersed in the bovine serum over the period of the test. The test specimens will
be placed under a 600 N load and articulated through 40o of dorsiflexion at a frequency of
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1 Hz. Test specimens should be removed, cleaned, and weighed and the bovine serum
replaced every 500,000 to 1,000,000 cycles, until test is complete. Test will be complete
upon implant failure or after 5,000,000 cycles, whichever comes first.
At the end of the test, the test specimen should be carefully cleaned, dried in a
vacuum oven, and weighed. Its loss of mass will then be corrected using the mass
gain/loss of the control specimen. The wear rate of the test specimen could then be
expressed in, for example, corrected loss of mass of implant (in mg) per 1 million loading
cycles.
As far as acceptance criteria are concerned, these should be developed by
studying clinical results and analyses of explanted prostheses (6). This type of
development is not uncommon when developing a new tester and evaluating the wear test
results. Bell and Fisher developed a new wear tester for an ankle joint prosthesis, but had
no existing data with which to compare their results (33). They tested an ankle implant
with a good clinical history to establish a baseline for a new design (33). Ellison et al
developed an in vitro wear tester for patellofemoral implants and tested designs currently
in clinical use (34). They then compared their results against explanted specimens to
determine the validity of their tester (34).
Caution should be exercised when developing acceptance criteria as it is known
that in vitro wear test results from THJRs and TKJRs do not always reflect clinical
results. Potentially, in vitro testing could lead to improved outcomes because it is carried
out in a controlled environment with repeatable fixturing, movements and forces.
Whereas it is easy to pinpoint excessive deformation or fracture of an implant, how much
mass loss the implant can experience and still function properly is somewhat subjective.
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Some observed wear rates of UHMWPE tibia inserts in TKJRs have been measured in
the range of 3.9 mm3 per million to 41.0 mm3per million cycles, with no mention of
prediction of lifespan (35). The wear rate for these implants is expected to be higher than
what would be observed in FMTPJ implants due to the large size of the femoral
components and the high amount of surface area contact in the knee.
An alternative to studying explants is radiographic evaluation of the implant in
vivo. Kendrick et al. performed an in vivo wear test study on unicompartmental KJRs
using patient radiographs to measure the linear penetration of the UHMWPE tibia insert
after an average of 20.9 years post implantation (36). They determined that the average
linear penetration of the insert was 1.04 mm, or 0.045mm/year (36).35 A similar type of
measurement method could be applied to analyzing results of in vitro wear tests on a
FMTPJ implant to see if the results obtained are similar to those observed clinically.
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Conclusions and Recommendations for Future Study
The first metatarsophalangeal joint (FMTPJ) is prone to many types of
disorders/diseases, notably, osteoarthritis and rheumatoid arthritis. In cases where the
pain due to a disease has not been relieved through the use of a conservative measure,
such as ingestion of an analgesic, or the disease is at an advanced stage, the usual
treatment option is arthrodesis. This option does, however, have a major limitation in that
it results in complete loss of motion at the joint. An alternative surgical method involves
insertion of an implant at the joint. Although there are many designs of FMTPJ implants
in clinical use, there are no literature reports on the design of FMTP implant wear testers.
In the present work, we designed such a tester, in which the implant under test will be 1)
housed in a chamber that contains bovine serum, at 37 oC, and 2) articulated at no less
than 40o dorsiflexion under a cyclic 600 N loading, at a frequency of 1 Hz. Furthermore,
the designed tester will be capable of testing any type of FMTPJ implant. Stress analysis
revealed that the highest stress occurs at the implant/fixture interface. Dividing the
material yield strength of 276MPa by the lowest and highest calculated equivalent
stresses on the remaining components, resulted in a factor of safety range of 5 to 126.
Various aspects of a wear test protocol, using the designed tester, as well as acceptance
criteria, based on clinical results, are presented.
Future work should be directed to validating results obtained using the designed
wear tester, for a wide collection of current-generation FMTPJ implants. Additional FEA
work should include analysis based on a dynamically applied load, as we only covered
static loading. Results are likely to change depending on the implant type and material
being tested. Validation of the software generated FEA results for deflection should be
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performed once the tester is built. Finished components can be measured for actual
deflection using resistance strain gages and the measured results can be compared with
the calculated results.
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